Frederick J. Ruegsegger, Director at Transcept Pharmaceuticals Inc (TSPT), bought 15,000 shares at $2.86 ($43K) on 2011-09-13, disclosed to the SEC on 2011-09-13.
Open-market purchase of $43k TSPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.